Healthcare Infection Control Practices Advisory Committee (HICPAC), 43547-43548 [2017-19778]
Download as PDF
<![CDATA[
43547
Federal Register / Vol. 82, No. 179 / Monday, September 18, 2017 / Notices
approved for the 2014 revision. This
reflects both a slight decrease in the
anticipated number of Health Hazard
Evaluation requests (300 to 290) as well
as changes in the response requirements
of requests received based upon recent
program experience.
Number of
respondents
Number of
responses per
respondent
Average
burden
per response
(in hours)
Type of respondent
Form
Employees/employee representatives/or employers.
Employees ......................................................
Health Hazard Evaluation Request Form ......
290
1
12/60
Health Hazard Evaluation specific interview
example.
Health Hazard Evaluation specific questionnaire example.
Employee Contact Postcard ..........................
Initial Site Visit Followback Survey form ........
2,580
1
15/60
3,700
1
30/60
2,150
244
1
1
5/60
10/60
Closeout for Health Hazard Evaluation
Followback Survey with site visit.
1 Year Later for Health Hazard Evaluation
Followback Survey with site visit.
Closeout for Health Hazard Evaluation without site visit.
244
1
20/60
244
1
15/60
98
1
10/60
1 Year Later for Health Hazard Evaluation
without site visit.
98
1
15/60
Employees ......................................................
Employees ......................................................
Follow-back for onsite evaluations—employer
& employee representative Year 1.
Employer & employee representative Year 1
Employer & employee representative Year 2
Follow-back for evaluations without onsite—
employer & employee representative Year
1.
Employer & employee representative Year 2
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2017–19744 Filed 9–15–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention (CDC)—Health Disparities
Subcommittee (HDS)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC) announces the
following meeting of the Advisory
Committee to the Director, Centers for
Disease Control and Prevention—Health
Disparities Subcommittee (ACD, CDC–
HDS). This meeting is open to the
public, limited only by the room that
accommodates 45 people and audio
phone line that accommodates 50
callers. The public is also welcome to
listen to the meeting by dialing 866–
918–8397 and enter code 9346283, this
conference line is available to the first
50 callers. The public comment period
sradovich on DSKBBY8HB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:54 Sep 15, 2017
Jkt 241001
is from 9:45 a.m. to 9:50 a.m. and 3:45
p.m. to 3:55 p.m. The deadline to
register for in-person attendance and/or
notice of intent to make oral or written
comment is October 30, 2017. To
register, please send an email to
ACDirector@cdc.gov.
DATES: The meeting will be held on
November 9, 2017, 8:30 a.m. to 4:00
p.m. ET.
ADDRESSES: CDC, Building 21, 12th
Floor, Rooms 12105–12101, 1600
Clifton Road NE., Atlanta, Georgia
30329.
Bridge line: 866–918–8397 and enter
code 9346283.
FOR FURTHER INFORMATION CONTACT:
Leandris Liburd, Ph.D., M.P.H., M.A.,
Designated Federal Officer, Health
Disparities Subcommittee, Advisory
Committee to the Director, CDC, 1600
Clifton Road NE., M/S K–77, Atlanta,
Georgia 30329. Telephone (404) 498–
6482, Email: ACDirector@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Subcommittee will
provide counsel to ACD, CDC on
strategic and other health disparities
and health equity issues and provide
guidance on opportunities for CDC.
Matters to be Considered: The Health
Disparities Subcommittee Agenda will
include discussions on addressing
health disparities in achieving the
agency’s overarching health impact
goals including selected observations
from the HDS for the ACD, CDC to
consider, and on progress of the HDS,
and on progress toward activities related
to data disaggregation and childhood
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
trauma. Agenda items are subject to
change as priorities dictate.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2017–19779 Filed 9–15–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee (HICPAC)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC), National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), announces the
following meeting for the Healthcare
Infection Control Practices Advisory
Committee (HICPAC). This meeting is
SUMMARY:
E:\FR\FM\18SEN1.SGM
18SEN1
43548
Federal Register / Vol. 82, No. 179 / Monday, September 18, 2017 / Notices
open to the public, limited only by room
seating available. The public is also
welcome to listen to the meeting by
866–836–4010, passcode: 18307719,
and, and 100 teleconference lines are
available.
The meeting will be held on
November 8, 2017, 9:00 a.m. to 5:00
p.m., EST and November 9, 2017, 9:00
a.m. to 12:00 p.m., EST.
ADDRESSES: Centers for Disease Control
and Prevention, Global Communications
Center, Building 19, Auditorium B, 1600
Clifton Road NE., Atlanta, Georgia
30329.
DATES:
Erin
Stone, M.A., HICPAC, Division of
Healthcare Quality Promotion, NCEZID,
CDC, l600 Clifton Road NE., Mailstop
A–07, Atlanta, Georgia 30329,
Telephone (404) 639–4045, Email:
hicpac@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged
with providing advice and guidance to
the Director, Division of Healthcare
Quality Promotion (DHQP), the Director,
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
the Director, CDC, the Secretary, Health
and Human Services regarding (1) the
practice of healthcare infection
prevention and control; (2) strategies for
surveillance, prevention, and control of
infections, antimicrobial resistance, and
related events in settings where
healthcare is provided; and (3) periodic
updating of CDC guidelines and other
policy statements regarding prevention
of healthcare-associated infections and
healthcare-related conditions.
Matters to be Considered: The agenda
will include updates on CDC’s activities
for prevention of healthcare associated
infections (HAIs), and DHQP’s modeling
efforts. It will also include updates from
the following HICPAC workgroups: The
Guideline for Prevention of Infection in
Neonatal Intensive Care Unit (NICU)
Patients; the Guideline for Prevention of
Infection in Healthcare Personnel; the
workgroup on updating the CDC
recommendation categorization scheme;
the workgroup on developing CDC
recommendations for products and
practices; and the National Healthcare
Safety Network (NHSN) Surveillance
Workgroup.
Agenda items are subject to change as
priorities dictate.
Time will be available for public
comment. The public is welcome to
submit written comments in advance of
the meeting. Comments should be
submitted in writing by email to the
contact person listed below. The
deadline for receipt is October 25, 2017.
sradovich on DSKBBY8HB2PROD with NOTICES
FOR FURTHER INFORMATION CONTACT:
VerDate Sep<11>2014
16:54 Sep 15, 2017
Jkt 241001
All requests must contain the name,
address, and organizational affiliation of
the speaker, as well as the topic being
addressed. Written comments should
not exceed one single-spaced typed page
in length and delivered in 3 minutes or
less. Members of the public who wish
to provide public comments should
plan to attend the public comment
session at the start time listed. Please
note that the public comment period
may end before the time indicated,
following the last call for comments.
Written comments received in advance
of the meeting will be included in the
official record of the meeting.
Registration is required to attend in
person or on the phone. Interested
parties may register at www.cdc.gov/
hicpac.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2017–19778 Filed 9–15–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–10292 and
CMS–R–148]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
SUMMARY:
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
other aspect of this collection of
information, including the necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions, the accuracy of
the estimated burden, ways to enhance
the quality, utility, and clarity of the
information to be collected; and the use
of automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
DATES: Comments on the collection(s) of
information must be received by the
OMB desk officer by October 18, 2017.
ADDRESSES: When commenting on the
proposed information collections,
please reference the document identifier
or OMB control number. To be assured
consideration, comments and
recommendations must be received by
the OMB desk officer via one of the
following transmissions: OMB, Office of
Information and Regulatory Affairs,
Attention: CMS Desk Officer, Fax
Number: (202) 395–5806 OR Email:
OIRA_submission@omb.eop.gov.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ Web site address at
Web site address at https://
www.cms.gov/Regulations-andGuidance/Legislation/Paperwork
ReductionActof1995/PRA-Listing.html.
2. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov.
3. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
William Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. The term ‘‘collection of
information’’ is defined in 44 U.S.C.
3502(3) and 5 CFR 1320.3(c) and
includes agency requests or
requirements that members of the public
submit reports, keep records, or provide
information to a third party. Section
3506(c)(2)(A) of the PRA (44 U.S.C.
3506(c)(2)(A)) requires federal agencies
to publish a 30-day notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension or
reinstatement of an existing collection
of information, before submitting the
collection to OMB for approval. To
comply with this requirement, CMS is
E:\FR\FM\18SEN1.SGM
18SEN1
]]>Agencies
[Federal Register Volume 82, Number 179 (Monday, September 18, 2017)]
[Notices]
[Pages 43547-43548]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-19778]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee
(HICPAC)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC), National Center for
Emerging and Zoonotic Infectious Diseases (NCEZID), announces the
following meeting for the Healthcare Infection Control Practices
Advisory Committee (HICPAC). This meeting is
[[Page 43548]]
open to the public, limited only by room seating available. The public
is also welcome to listen to the meeting by 866-836-4010, passcode:
18307719, and, and 100 teleconference lines are available.
DATES: The meeting will be held on November 8, 2017, 9:00 a.m. to 5:00
p.m., EST and November 9, 2017, 9:00 a.m. to 12:00 p.m., EST.
ADDRESSES: Centers for Disease Control and Prevention, Global
Communications Center, Building 19, Auditorium B, 1600 Clifton Road
NE., Atlanta, Georgia 30329.
FOR FURTHER INFORMATION CONTACT: Erin Stone, M.A., HICPAC, Division of
Healthcare Quality Promotion, NCEZID, CDC, l600 Clifton Road NE.,
Mailstop A-07, Atlanta, Georgia 30329, Telephone (404) 639-4045, Email:
hicpac@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged with providing advice and
guidance to the Director, Division of Healthcare Quality Promotion
(DHQP), the Director, National Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), the Director, CDC, the Secretary, Health
and Human Services regarding (1) the practice of healthcare infection
prevention and control; (2) strategies for surveillance, prevention,
and control of infections, antimicrobial resistance, and related events
in settings where healthcare is provided; and (3) periodic updating of
CDC guidelines and other policy statements regarding prevention of
healthcare-associated infections and healthcare-related conditions.
Matters to be Considered: The agenda will include updates on CDC's
activities for prevention of healthcare associated infections (HAIs),
and DHQP's modeling efforts. It will also include updates from the
following HICPAC workgroups: The Guideline for Prevention of Infection
in Neonatal Intensive Care Unit (NICU) Patients; the Guideline for
Prevention of Infection in Healthcare Personnel; the workgroup on
updating the CDC recommendation categorization scheme; the workgroup on
developing CDC recommendations for products and practices; and the
National Healthcare Safety Network (NHSN) Surveillance Workgroup.
Agenda items are subject to change as priorities dictate.
Time will be available for public comment. The public is welcome to
submit written comments in advance of the meeting. Comments should be
submitted in writing by email to the contact person listed below. The
deadline for receipt is October 25, 2017. All requests must contain the
name, address, and organizational affiliation of the speaker, as well
as the topic being addressed. Written comments should not exceed one
single-spaced typed page in length and delivered in 3 minutes or less.
Members of the public who wish to provide public comments should plan
to attend the public comment session at the start time listed. Please
note that the public comment period may end before the time indicated,
following the last call for comments. Written comments received in
advance of the meeting will be included in the official record of the
meeting. Registration is required to attend in person or on the phone.
Interested parties may register at www.cdc.gov/hicpac.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2017-19778 Filed 9-15-17; 8:45 am]
BILLING CODE 4163-18-P
